AF_AFQ9H6Z9F1

Computed structure model of Prolyl hydroxylase EGLN3

External Resource: Annotation

Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Prolyl hydroxylase EGLN3	cation binding transition metal ion binding iron ion binding ion binding binding ferrous iron binding metal ion binding small molecule binding peptidyl-proline 4-dioxygenase activity oxidoreductase activity catalytic activity, acting on a protein oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen peptidyl-proline dioxygenase activity catalytic activity cation binding transition metal ion binding iron ion binding ion binding binding ferrous iron binding metal ion binding small molecule binding peptidyl-proline 4-dioxygenase activity oxidoreductase activity catalytic activity, acting on a protein oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen peptidyl-proline dioxygenase activity catalytic activity 2-oxoglutarate-dependent dioxygenase activity dioxygenase activity organic acid binding carbohydrate binding vitamin binding anion binding monosaccharide binding carboxylic acid binding heterocyclic compound binding L-ascorbic acid binding hypoxia-inducible factor-proline dioxygenase activity	cellular response to stimulus cellular response to stress response to stimulus DNA damage response response to stress cellular process regulation of protein stability biological regulation regulation of biological quality protein stabilization response to decreased oxygen levels cellular response to oxygen levels cellular response to hypoxia cellular response to decreased oxygen levels cellular response to stimulus cellular response to stress response to stimulus DNA damage response response to stress cellular process regulation of protein stability biological regulation regulation of biological quality protein stabilization response to decreased oxygen levels cellular response to oxygen levels cellular response to hypoxia cellular response to decreased oxygen levels cellular response to chemical stimulus response to hypoxia response to chemical response to oxygen levels response to abiotic stimulus macromolecule modification protein hydroxylation metabolic process primary metabolic process protein metabolic process macromolecule metabolic process protein modification process apoptotic process cell death programmed cell death regulation of biological process neuron apoptotic process regulation of cellular process regulation of apoptotic process regulation of programmed cell death regulation of neuron apoptotic process negative regulation of ferroptosis negative regulation of programmed cell death negative regulation of biological process negative regulation of cellular process regulation of ferroptosis ferroptosis	cellular anatomical structure intracellular anatomical structure cytoplasm cytosol membrane-bounded organelle nucleus membrane-enclosed lumen intracellular membrane-bounded organelle intracellular organelle lumen intracellular organelle nucleoplasm organelle lumen organelle nuclear lumen

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR006620	Prolyl 4-hydroxylase, alpha subunit	Domain
A	IPR044862	Prolyl 4-hydroxylase alpha subunit, Fe(2+) 2OG dioxygenase domain	Domain
A	IPR051559	Hypoxia-inducible factor prolyl hydroxylases	Family
A	IPR005123	Oxoglutarate/iron-dependent dioxygenase domain	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q9H6Z9	liver cancer pancreatic intraductal papillary-mucinous carcinoma primitive neuroectodermal tumor Anemia in chronic kidney disease atopic eczema ductal breast carcinoma in situ large cell medulloblastoma lung adenocarcinoma malignant pancreatic neoplasm oligodendroglioma pancreatic intraductal papillary-mucinous neoplasm attention deficit hyperactivity disorder, inattentive type malignant ependymoma medulloblastoma ovarian cancer liver cancer pancreatic intraductal papillary-mucinous carcinoma primitive neuroectodermal tumor Anemia in chronic kidney disease atopic eczema ductal breast carcinoma in situ large cell medulloblastoma lung adenocarcinoma malignant pancreatic neoplasm oligodendroglioma pancreatic intraductal papillary-mucinous neoplasm attention deficit hyperactivity disorder, inattentive type malignant ependymoma medulloblastoma ovarian cancer pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia astrocytic tumor atypical teratoid rhabdoid tumor invasive ductal breast carcinoma liver neoplasm malignant mesothelioma non-small cell lung carcinoma

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

Prepare Data

Validate Data